1. Auty R.M. (1994): Creating a management structure that minimises time loss and maximises cost savings. Case histories of what worked and what did not. Data presented at the Henry Stewart Conference on: Resolving the problems that delay the commencement of clinical trials. CFS Conference Centre, London 28–29 April 1994.
2. Campbell D.B., Jochemsen R. (1994): Animal pharmacokinetics and toxicokinetics. In: Cartwright A.C., Matthews B.R. (eds), International Pharmaceutical Product Registration: Aspects of Quality, Safety and Efficacy. London, Ellis Horwood, London, pp. 569–627.
3. Warrander A. (1992). Preclinical metabolism and pharmacokinetic prospects for harmonisation questionnaire: Interim results. Macclesfield, Zeneca Pharmaceuticals.
4. Warrander A. (1993): Harmonisation of preclinical metabolism and pharmacokinetic: Interim results of questionnaire. ISSX Newsletter, 12(1), 12–13.
5. Warrander A. (1994): Around the world with 80+ companies — a review of toxicokinetic practices. Drug Inf. J., 28, 281–283.